Pathophysiology and Clinical Implications of Ascites in Cirrhosis

Primary Pathophysiological Mechanisms

Portal hypertension is a prerequisite for ascites development in cirrhosis, occurring due to structural changes in liver architecture from progressive collagen deposition and nodule formation, as noted by the European Association for the Study of the Liver 3, 4
Increased resistance to portal flow occurs from architectural distortion of the liver vasculature in cirrhosis, activated hepatic stellate cells, and reduced nitric oxide production/bioavailability in the cirrhotic liver, accounting for approximately 25% of increased resistance, according to the British Society of Gastroenterology 4, 5
Splanchnic arterial vasodilation is triggered by elevated portal pressure, production of vasodilators including nitric oxide, prostacyclin, and endocannabinoids, leading to "effective hypovolemia" despite total body fluid overload, as reported by the American Association for the Study of Liver Diseases 2, 3, 4

Decreased effective arterial blood volume activates compensatory mechanisms, including sympathetic nervous system activation, renin-angiotensin-aldosterone system activation, and non-osmotic release of arginine vasopressin, promoting sodium and water retention, as described by the International Ascites Club 1, 2, 4
The resulting positive sodium balance leads to expansion of extracellular fluid volume, accumulation of fluid in the peritoneal cavity, and portal hypertension acting as a compartmentalizing factor for the expanded fluid volume, according to the European Association for the Study of the Liver 1, 2

Ascites is the most common complication of cirrhosis, developing in 5-10% of compensated cirrhotic patients annually, and marks significant disease progression, reducing 5-year survival from 80% in compensated cirrhosis to approximately 30%, as noted by the American Association for the Study of Liver Diseases 1
Development of ascites predisposes to additional complications, including spontaneous bacterial peritonitis, restrictive ventilatory dysfunction, and abdominal hernias, according to the European Association for the Study of the Liver 1

Diagnostic paracentesis is essential for all patients with new-onset grade 2-3 ascites, and serum-ascites albumin gradient (SAAG) ≥1.1 g/dL confirms portal hypertension as the cause with 97% accuracy, as recommended by the American Association for the Study of Liver Diseases 1, 7
Neutrophil count, culture, and total protein concentration should be assessed to evaluate for spontaneous bacterial peritonitis and infection risk, according to the Infectious Diseases Society of America 1